Abstract
The Leeds Behçet’s disease quality-of-life (BD-QoL) questionnaire is a specific and valid measure which is applied in English-speaking patients. We conducted Persian adaptation of BD-QoL questionnaire. Between June and December 2012, 220 Iranian patients fulfilling International Study Group criteria for the diagnosis of BD attending the rheumatology clinics at Tehran University of Medical Sciences were enrolled. Bilingual translators undertook the forward translation and cross-cultural adaptation of the BD-QoL questionnaire. Back-translation was conducted, and this version was sent to the designer of the questionnaire and revised accordingly. SF-36 health survey, Iranian Behçet’s disease dynamic activity measure (IBDDAM), and Behçet’s Disease Current Activity Form (BDCAF) were other administered measures. The Varimax rotation method with Kaiser normalization defined 5 factors with eigenvalues greater than 1.0. Studied cases were comprised of 118 males (53.6 %) and 102 females (46.4 %). Mean age of the patients was 38.3 ± 11.3 years (range 16–73). The mean BD-QoL score was 10.3 ± 8.8. Test–retest reliability was high, and two time points were significantly correlated (Spearman’s correlation coefficient of 0.75–0.84). Cronbach’s α coefficient of 0.949 demonstrated the excellent internal consistency. These factors cumulatively explained 58.74 % of total variance. The ratio of first to second eigenvalue was 7.08, which underlined the undimensionality. The results revealed adapted BD-QoL scores had significant correlation with IBDDAM (correlation coefficient = 0.19, P value = 0.005) and BDCAF (correlation coefficient = 0.21, P value = 0.002). Conversely, no significant correlation between BD-QoL and SF-36 results was detected (P value = 0.078). The Persian version of BD-QoL was shown to be unidimensional, highly reliable, and adequate construct validity.
Similar content being viewed by others
References
Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M et al (2010) Behcet’s disease in Iran: analysis of 6500 cases. Int J Rheum Dis. 13(4):367–373
Kaneko F, Nakamura K, Sato M, Tojo M, Zheng X, Zhang JZ (2003) Epidemiology of Behcet’s disease in Asian countries and Japan. Adv Exp Med Biol 528:25–29
Zouboulis CC (1999) Epidemiology of Adamantiades-Behcet’s disease. Ann Med Intern (Paris) 150(6):488–498
Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M et al (2010) Behcet’s disease: from east to west. Clin Rheumatol 29(8):823–833
Kaneko F, Togashi A, Saito S, Sakuma H, Oyama N, Nakamura K et al (2011) Behcet’s disease (Adamantiades-Behcet’s disease). Clin Dev Immunol 2011:681956
Mumcu G, Inanc N, Ergun T, Ikiz K, Gunes M, Islek U et al (2006) Oral health related quality of life is affected by disease activity in Behcet’s disease. Oral Dis 12(2):145–151
Gilworth G, Chamberlain MA, Bhakta B, Haskard D, Silman A, Tennant A (2004) Development of the BD-QoL: a quality of life measure specific to Behcet’s disease. J Rheumatol 31(5):931–937
Gur A, Sarac AJ, Burkan YK, Nas K, Cevik R (2006) Arthropathy, quality of life, depression, and anxiety in Behcet’s disease: relationship between arthritis and these factors. Clin Rheumatol 25(4):524–531
Tanriverdi N, Taskintuna Duru C, Ozdal P, Ortac S, Firat E (2003) Health-related quality of life in Behcet patients with ocular involvement. Jpn J Ophthalmol 47(1):85–92
Kievit W, Fransen J, de Waal Malefijt MC, den Broeder AA, van Riel PL (2013) Treatment changes and improved outcomes in RA: an overview of a large inception cohort from 1989 to 2009. Rheumatology (Oxford) 52(8):1500–1508
Blackford S, Finlay AY, Roberts DL (1997) Quality of life in Behcet’s syndrome: 335 patients surveyed. Br J Dermatol 136(2):293
Bodur H, Borman P, Ozdemir Y, Atan C, Kural G (2006) Quality of life and life satisfaction in patients with Behcet’s disease: relationship with disease activity. Clin Rheumatol 25(3):329–333
Moses Alder N, Fisher M, Yazici Y (2008) Behcet’s syndrome patients have high levels of functional disability, fatigue and pain as measured by a Multi-dimensional Health Assessment Questionnaire (MDHAQ). Clin Exp Rheumatol 26(4 Suppl 50):S110–S113
Guyatt GH, Feeny DH, Patrick DL (1993) Measuring health-related quality of life. Ann Intern Med 118(8):622–629
Ertam I, Kitapcioglu G, Aksu K, Keser G, Ozaksar A, Elbi H et al (2009) Quality of life and its relation with disease severity in Behcet’s disease. Clin Exp Rheumatol 27(2 Suppl 53):S18–S22
Hirayama MS, Gobbi S, Gobbi LT, Stella F (2008) Quality of life (QoL) in relation to disease severity in Brazilian Parkinson’s patients as measured using the WHOQOL-BREF. Arch Gerontol Geriatr 46(2):147–160
Touma Z, Ghandour L, Sibai A, Puzantian H, Hamdan A, Hamdan O et al (2011) Cross-cultural adaptation and validation of Behcet’s disease quality of life questionnaire. BMC Med Res Methodol 11:52
Yi SW, Kim JH, Lim KY, Bang D, Lee S, Lee ES (2008) The Behcet’s Disease Quality of Life: reliability and validity of the Korean version. Yonsei Med J 49(5):698–704
(1990) Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s Disease. Lancet 335(8697):1078–1080
Ware JE Jr, Sherbourne CD (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483
Shahram F, Khabbazi A, Nadji A, Ziaie N, Banihashemi AT, Davatchi F (2009) Comparison of existing disease activity indices in the follow-up of patients with Behcet’s disease. Mod Rheumatol 19(5):536–541
Jamshidi A, Shahram F, Akbarian M, Gharibdoost F, Nadji A, Chams C (2001) The accuracy of IBDDAM (Iran Behcet’s disease dynamic measure) in the treatment evaluation of Behcet’s disease. APLAR J Rheumatol 4:161–163
Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ (1999) Behcet’s disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford) 38(8):728–733
Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 25(24):3186–3191
Black R, Lester S, Dunstan E, Shahram F, Nadji A, Bayat N et al (2012) Fc-gamma receptor 3B copy number variation is not a risk factor for Behcet’s disease. Int J Rheumatol 2012:167096
Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P (2000) Endpoints: consensus recommendations from OMERACT IV. Outcome measures in rheumatology. Lupus 9(5):322–327
Ertam I, Kitapcioglu G, Aksu K, Keser G, Ozaksar A, Elbi H et al (2009) Quality of life and its relation with disease severity in Behçet’s disease. Clin Exp Rheumatol 27(2):S18
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vojdanian, M., Faezi, S.T., Tennant, A. et al. Validity and reliability of the Persian version of Behçet’s disease quality-of-life (BD-QoL) questionnaire: a cross-cultural adaptation. Rheumatol Int 35, 677–684 (2015). https://doi.org/10.1007/s00296-014-3128-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-014-3128-6